IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Amicus Therapeutics Inc (FOLD)

CUSIP: 03152W109 | NYSE | Healthcare · Biotechnology | Mid Cap | 1017 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AThe Goldman Sachs Group, Inc.00.0%No shares heldJun 30, 2026No 13F filer matched
13G/AThe Goldman Sachs Group, Inc.0
0.0% of class · Jun 30, 2026No shares held
No 13F filer matched

Institutional Holders — Q2 2026

IFP Advisors, Inc796
0.0% of portfolio›$11.5K
Huntington National Bank1
0.0% of portfolio›$14
StyleTurnoverLocationFiled
IFP Advisors, Inc
796$11.5K0.0%GrowthLowTampa, FL2026-07-20
Huntington National Bank
1$140.0%GrowthLowColumbus, OH2026-08-13